InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,475.72
(
-0.21%
)
US TECH 100
19,249.60
(
-0.82%
)
Dow Jones
39,103.39
(
0.69%
)
Brent Oil
85.10
(
0.47%
)
Bitcoin
64,977.77
(
0.02%
)
Post# of 2804248
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Suarezzz1111

Send PM Follow Ignore
Followers 4
Posts 382
Boards Moderated 0
Alias Born 05/11/2016

Suarezzz1111

Re: None

Friday, 09/15/2017 11:05:43 AM

Friday, September 15, 2017 11:05:43 AM

Post# of 2804248
Not sure who's watching but OXISD has been making some waves in the biotech sector with their therapy TriKE. TriKE offers a platform to target ligands that can be incorporated and has the ability to stimulate endogenous NK cells. simply put, this process can bypass the need for cell transfers altogether and make way for a new generation of immunotherapeutics.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up